Tsuchiya, M.; Kayamori, K.; Wada, A.; Komaki, M.; Ohata, Y.; Hamagaki, M.; Sakamoto, K.; Ikeda, T.
A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol. Int. J. Mol. Sci. 2019, 20, 6211.
https://doi.org/10.3390/ijms20246211
AMA Style
Tsuchiya M, Kayamori K, Wada A, Komaki M, Ohata Y, Hamagaki M, Sakamoto K, Ikeda T.
A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol. International Journal of Molecular Sciences. 2019; 20(24):6211.
https://doi.org/10.3390/ijms20246211
Chicago/Turabian Style
Tsuchiya, Maiko, Kou Kayamori, Akane Wada, Motohiro Komaki, Yae Ohata, Miwako Hamagaki, Kei Sakamoto, and Tohru Ikeda.
2019. "A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol" International Journal of Molecular Sciences 20, no. 24: 6211.
https://doi.org/10.3390/ijms20246211
APA Style
Tsuchiya, M., Kayamori, K., Wada, A., Komaki, M., Ohata, Y., Hamagaki, M., Sakamoto, K., & Ikeda, T.
(2019). A Novel, Tumor-Induced Osteoclastogenesis Pathway Insensitive to Denosumab but Interfered by Cannabidiol. International Journal of Molecular Sciences, 20(24), 6211.
https://doi.org/10.3390/ijms20246211